CatalystAlert

Search CatalystAlert

Search for companies, drugs, and catalysts

Search CatalystAlert

Search for companies, drugs, and catalysts

yahoo_finance
Original article

Enlivex's Allocetra Receives FDA RMAT Designation for Knee Osteoarthritis

RegulatoryAllocetraPositive
AI Analysis

Summary

Enlivex's Allocetra has received FDA Regenerative Medicine Advanced Therapy (RMAT) designation for knee osteoarthritis, expediting the development pathway.

Outcome Details

RMAT designation received

Importance:6/10
Sentiment:
0.70
RMAT DesignationFDAOsteoarthritisRegulatory
Related Companies

Read the original article

Published by yahoo_finance on July 13, 2026 12:33 PM

Read Original